Orexo AB (FRA:C5G) Cyclically Adjusted Book per Share: €0.96 (As of Mar. 2026)


FRA:C5G Orexo AB FRA:C5G
36 GF Score
Price €2.16
GF Value €0.56
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Orexo AB Cyclically Adjusted Book per Share?

Orexo AB FRA:C5G +0.47% 36 Cyclically Adjusted Book per Share is €0.96 as of Mar. 2026. GuruFocus rates FRA:C5G with a GF Score™ of 36/100 and a GF Value™ of €0.56 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Orexo AB's adjusted book value per share for the three months ended in Mar. 2026 was €0.964. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.96 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Orexo AB's average Cyclically Adjusted Book Growth Rate was -6.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -6.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Orexo AB was 3.30% per year. The lowest was -6.20% per year. And the median was -1.40% per year.

As of today (2026-07-08), Orexo AB's current stock price is €2.155. Orexo AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €0.96. Orexo AB's Cyclically Adjusted PB Ratio of today is 2.24.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Orexo AB was 6.84. The lowest was 0.69. And the median was 2.49.


Orexo AB  (FRA:C5G) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Orexo AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.155/0.96
=2.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Orexo AB was 6.84. The lowest was 0.69. And the median was 2.49.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Orexo AB Cyclically Adjusted Book per Share Related Terms


Orexo AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Orexo AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orexo AB Cyclically Adjusted Book per Share Chart

Orexo AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.11 1.16 1.18 1.03 0.97

Orexo AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 0.88 0.91 0.97 0.96

FRA:C5G vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orexo AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Orexo AB's Cyclically Adjusted PB Ratio falls into.


FRA:C5G
36GF Score
Orexo AB FRA:C5G
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orexo AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orexo AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.964/133.5600*133.5600
=0.964

Current CPI (Mar. 2026) = 133.5600.

Orexo AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.748 101.019 0.989
201609 0.819 101.138 1.082
201612 0.925 102.022 1.211
201703 0.830 102.022 1.087
201706 0.819 102.752 1.065
201709 0.910 103.279 1.177
201712 0.959 103.793 1.234
201803 0.868 103.962 1.115
201806 1.017 104.875 1.295
201809 1.177 105.679 1.488
201812 1.341 105.912 1.691
201903 1.367 105.886 1.724
201906 1.498 106.742 1.874
201909 1.810 107.214 2.255
201912 1.942 107.766 2.407
202003 2.076 106.563 2.602
202006 2.050 107.498 2.547
202009 1.732 107.635 2.149
202012 1.601 108.296 1.974
202103 1.533 108.360 1.890
202106 1.324 108.928 1.623
202109 1.179 110.338 1.427
202112 0.992 112.486 1.178
202203 0.911 114.825 1.060
202206 0.847 118.384 0.956
202209 0.804 122.296 0.878
202212 0.513 126.365 0.542
202303 0.335 127.042 0.352
202306 0.308 129.407 0.318
202309 0.226 130.224 0.232
202312 0.153 131.912 0.155
202403 0.158 132.205 0.160
202406 0.062 132.716 0.062
202409 -0.069 132.304 -0.070
202412 -0.318 132.987 -0.319
202503 -0.427 132.825 -0.429
202506 -0.518 133.699 -0.517
202509 -0.587 133.480 -0.587
202512 1.299 133.390 1.301
202603 0.964 133.560 0.964

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.96 mean?
Orexo AB (FRA:C5G) has a Cyclically Adjusted Book per Share of €0.96 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Orexo AB and its competitors.
Is Orexo AB's Cyclically Adjusted Book per Share too high?
Orexo AB's current Cyclically Adjusted Book per Share is €0.96. Overall, Orexo AB has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Orexo AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Orexo AB's Cyclically Adjusted Book per Share of €0.96 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Orexo AB and its competitors. Orexo AB's current Cyclically Adjusted Book per Share is €0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orexo AB stock overvalued right now?
Based on GuruFocus' analysis, Orexo AB (FRA:C5G) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.56, compared to a current price of €2.16 — trading 284.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is €0.96. Orexo AB's overall GF Score™ is 36/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Orexo AB (FRA:C5G), the current Cyclically Adjusted Book per Share is €0.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orexo AB (FRA:C5G) Overvalued in 2026?

Based on GuruFocus' analysis, Orexo AB stock appears to be overvalued. The current stock price of €2.16 is trading 284.8% above its estimated GF Value™ of €0.56. GuruFocus considers Orexo AB to be Significantly Overvalued.

Key valuation signals for FRA:C5G:

  • Cyclically Adjusted Book per Share: €0.96
  • GF Value™: €0.56 vs. price of €2.16 (284.8% above fair value)
  • GF Score™: 36/100 with 8 warning signs

No single metric tells the full story. See the FRA:C5G stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Orexo AB Business Description

Address Virdings alle 22, Uppsala, SWE, 75105
Orexo AB is a Swedish pharmaceutical company dedicated to advancing treatments for severe diseases and life-saving rescue medications to meet future healthcare needs, developing improved medications based on proprietary drug delivery technologies. At the core of its innovation is AmorphOX, which improves bioavailability and stability for both large and small molecules. It has developed four drugs from concept to approval, including Zubsolv, Abstral, Edluar, and Diabact UBT. The company's current development efforts focus on AmorphOX, with projects in preclinical and clinical phases across multiple therapeutic areas. It operates through US Commercial and HQ & Pipeline, which generate maximum revenue, and operates in the US, EU, and UK generating maximum revenue, and the Rest of the World.
36GF Score

Get the complete analysis for FRA:C5G

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.16
Price
€0.56
GF Value